Preliminary safety in the inavolisib + fulvestrant + ribociclib/abemaciclib arms of MORPHEUS-pan breast cancer: a Phase 1b/2 study of efficacy & safety of multiple treatment combinations in patients with metastatic/locally advanced breast cancer Available

Authors
Category Systematic review
ConferenceClinical cancer research
Year 2025
This article has no abstract
Epistemonikos ID: 27fad93c012d649008dd760b06780dca4764f130
First added on: Feb 16, 2026